Comarco (CMRO) 10-Q 14 Jun 17 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Apr. 30, 2017	Jun. 14, 2017
Document Information [Line Items]
Entity Registrant Name	Comarco Inc
Entity Central Index Key	22,252
Trading Symbol	cmro
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		14,614,165
Document Type	10-Q
Document Period End Date	Apr. 30, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Apr. 30, 2017	Jan. 31, 2017
ASSETS
Cash and cash equivalents	$ 377	$ 618
Other current assets	44	14
Total current assets	421	632
Total assets	421	632
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	9	6
Accrued liabilities	387	384
Income taxes payable	5	5
Total current liabilities	401	395
Total liabilities	401	395
Commitments and Contingencies (Note 8)
Stockholders' Equity:
Preferred stock, no par value, 10,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $0.10 par value, 50,625,000 shares authorized; 14,614,165 shares issued and outstanding at April 30, 2017 and January 31, 2017	1,461	1,461
Additional paid-in capital	18,415	18,410
Accumulated deficit	(19,856)	(19,634)
Total stockholders' equity	20	237
Total liabilities and stockholders' equity	$ 421	$ 632

Consolidated Balance Sheets (C3

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Apr. 30, 2017	Jan. 31, 2017
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized (in shares)	50,625,000	50,625,000
Common stock, shares issued (in shares)	14,614,165	14,614,165
Common stock, shares outstanding (in shares)	14,614,165	14,614,165

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Revenue
Cost of revenue
Gross profit
Selling, general and administrative expenses	222	364
	222	364
Operating loss	(222)	(364)
Other income, net		1,688
(Loss) income from operations before income taxes	(222)	1,324
Income tax expense
Net (loss) income	$ (222)	$ 1,324
Basic (loss) income per share: (in dollars per share)	$ (0.02)	$ 0.09
Diluted (loss) income per share: (in dollars per share)	$ (0.02)	$ 0.09
Weighted-average shares outstanding:
Basic (in shares)	14,615	14,644
Diluted (in shares)	14,615	14,644

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ (222)	$ 1,324
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization		1
Stock-based compensation expense	5	13
Changes in operating assets and liabilities
Other assets	(30)	(35)
Accounts payable	3	(504)
Accrued liabilities	3	(32)
Net cash (used in) provided by operating activities	(241)	767
Net (decrease) increase in cash and cash equivalents	(241)	767
Cash and cash equivalents, beginning of period	618	680
Cash and cash equivalents, end of period	377	1,447
Supplementary disclosures of cash flow information:
Cash paid for income taxes, net of refunds

Note 1 - Organization

Note 1 - Organization	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. Organization Comarco, Inc. was incorporated in California in 1960 1971, September 1993.

Note 2 - Current Developments,

Note 2 - Current Developments, Future Operations, Liquidity and Capital Resources	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Going Concern [Text Block]	2. Current Developments, Future Operations, Liquidity and Capital Resources The unaudited consolidated financial statements have been prepared assuming that we will continue to operate as a going concern, which contemplates that we will realize returns on our assets and satisfy our liabilities and commitments in the ordinary course of business. As of April 30, 2017, $20,000, not twelve no no no no not Our business is currently focused on potentially realizing value from our ongoing or future IP enforcement actions and other litigation as well as further exploring opportunities to expand, protect, and monetize our patent portfolio, including through the potential sale or licensing of some or all of our patent portfolio. On February 3, 2015, 20 September 2015, No. 8,492,933 B2 “933 February 22, 2017, 12 may no no On February 13, 2015, inter partes inter partes We have and will continue to analyze alternatives to build and/or preserve value for our stakeholders, including, but not no We believe that our patent portfolio covering key technical aspects of our products could potentially generate a future revenue stream based upon royalties paid to us by others for the use of some or all of our patented technology in third may may not no

Note 3 - Summary of Significant

Note 3 - Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Significant Accounting Policies [Text Block]	3. Summary of Significant Accounting Policies The summary of our significant accounting policies presented below is designed to assist the reader in understanding our consolidated financial statements. Such financial statements and related notes are the representations of our management, who are responsible for their integrity and objectivity. Basis of Presentation The accompanying consolidated balance sheet as of January 31, 2017, three April 30, 2017 10 8 X. not not 10 January 31, 2017 “2016 10 May 1, 2017. 3 2017 10 three April 30, 2017 not January 31, 2018. Reclassification Certain prior year and prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no Principles of Consolidation The unaudited interim consolidated financial statements of the Company include the accounts of Comarco, Inc. and CWT, its wholly owned subsidiary. All material intercompany balances, transactions, and profits and losses have been eliminated. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the periods reported. Actual results could materially differ from those estimates. Certain accounting principles require subjective and complex judgments to be used in the preparation of financial statements. Accordingly, a different financial presentation could result depending on the judgments, estimates, or assumptions that are used. Such estimates and assumptions include, but are not Cash and Cash Equivalents All highly liquid investments with original maturity dates of three Fair Value of Financial Instruments Our financial instruments include cash and cash equivalents, accounts payable and accrued liabilities. The carrying amount of cash and cash equivalents, accounts payable, and accrued liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments. Legal expense classification Our legal expenses are classified in either selling, general, and administrative expenses. All legal expenses incurred related to our intellectual property, including associated litigation expense and maintenance of our patent portfolio, public company legal expense, and all other litigation expense are included in selling, general, and administrative expenses in our consolidated statement of operations. Income tax expense Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and any required valuation allowance. We continue to maintain a full valuation allowance on the entire deferred tax asset balance. This valuation allowance was established based on management’s overall assessment of risks and uncertainties related to our future ability to realize, and hence, utilize certain deferred tax assets, primarily consisting of net operating loss carry forwards and temporary differences. Due to the current and prior years’ operating losses, the adjusted net deferred tax assets remained fully reserved as of April 30, 2017. Net Income (Loss) Per Common Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period excluding the dilutive effect of potential common stock, which for us consists solely of stock awards. Diluted earnings per share reflects the dilution that would result from the exercise of all dilutive stock awards outstanding during the period. The effect of such potential common stock is computed using the treasury stock method (see Note 5 Recent Accounting Pronouncements In February 2016, 2016 02, 842 2016 02” 2016 02 December 15, 2018, 2016 02 first 2020. not not In May 2014, 2014 09, 606 2014 09 five 2014 09 April 1, 2015, one December 15, 2018. 2014 09 first 2020. not not not We do not not Subsequent Events Management has evaluated events subsequent to April 30, 2017 may As of April 1, 2017, $4,500 $3,000 $1,500 $1,250 $0 $1,250 10Q $3.0

Note 4 - Stock-Based Compensati

Note 4 - Stock-Based Compensation	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	4. Stock-Based Compensation We grant stock awards for a fixed number of shares to employees, consultants, and directors pursuant to our shareholder-approved equity incentive plans. We account for stock-based compensation using the modified prospective method, which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using a Lattice Binomial model for options with performance-based vesting tied to our stock price and the Black-Scholes valuation model for options with ratable term vesting. Both the Lattice Binomial and Black-Scholes valuation models require the input of subjective assumptions. These assumptions include estimating the length of time optionees will retain their vested stock options before exercising them (the “expected term”), the estimated volatility of our common stock price over the expected term, and the number of awards that will ultimately not may The compensation expense recognized is summarized in the table below (in thousands except per share amounts): Three Months Ended April 30, 2017 2016 Stock-based compensation expense $ 7 $ 13 Impact on basic and diluted earnings per share $ (0.00 ) $ (0.00 ) The total compensation cost related to unvested awards not $13,500 third 2018. During the three April 30, 2017 2016, no no Transactions and other information related to stock options granted under these plans for the three April 30, 2017 Outstanding Options Weighted-Ave. Number of Exercise Shares Price Balance, January 31, 2017 1,100,000 $ 0.37 Options granted - - Options canceled or expired - - Options exercise - - Balance, April 30, 2017 1,100,000 $ 0.37 Stock Options Exercisable at April 30, 2017 760,000 $ 0.44 As of April 30, 2017, $0, $0.06 April 30, 2017. April 30, 2017: Awards Outstanding Options Exercisable Weighted-Ave. Range of Number Remaining Weighted-Ave. Number Weighted-Ave. Exercise/Grant Prices Outstanding Contractual Life Exercise/Grant Price Exercisable Exercise Price $0.09 300,000 9.50 $ 0.09 - $ 0.09 $0.14 - $0.16 300,000 8.14 $ 0.15 300,000 $ 0.15 $0.40 385,000 5.26 $ 0.40 385,000 $ 0.40 $1.09 100,000 1.53 $ 1.09 60,000 $ 1.09 $4.53 15,000 0.84 $ 4.53 15,000 $ 4.53 1,100,000 760,000 Shares available under the plans for future grants at April 30, 2017 323,535.

Note 5 - Net (Loss) Income Per

Note 5 - Net (Loss) Income Per Share	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Earnings Per Share [Text Block]	5. Net (Loss) Income Per Share We calculate basic (loss) income per share by dividing net (loss) by the weighted-average number of common shares outstanding during the reporting period. Diluted (loss) income per share reflects the effects of dilutive potential common shares. Because we incurred a net loss for the three April 30, 2017, three April 30, 2016, Potential common shares of 3,190,000 3,073,736 three April 30, 2017 2016, The following table presents reconciliations of the numerators and denominators of the basic and diluted loss per share computations for net (loss) income. In the tables below, “Net (loss) income” represents the numerator and “shares” represents the denominator (in thousands, except per share amounts): Three Months Ended April 30, 2017 2016 Net (loss) income $ (222 ) $ 1,324 Basic net income (loss) per share: Weighted-average shares outstanding-Basic 14,615 14,644 Basic net (loss) income per share $ (0.02 ) $ 0.09 Diluted net (loss) income per share: Weighted average shares outstanding - basic 14,615 14,644 Effect of potentially dilutive securities - - Weighted average shares outstanding - diluted 14,615 14,644 Diluted net (loss) income per share $ (0.02 ) $ 0.09

Note 6 - Concentrations

Note 6 - Concentrations	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	6. Concentrations The companies that comprise 10 April 30, 2017 January 31, 2017 As of April 30, As of January 31, 2017 2017 Total gross accounts payable $ 9 100 % $ 6 100 % Vendor concentration: Fuan Gee Mechanical Industrial Co. 3 34 % 3 50 % RentShare 2 22 % 2 33 % CNA Insurance 2 22 % 1 17 % Computershare, Inc. 2 22 % - 0 % $ 9 100 % $ 6 100 % Fuan Gee was an audio plug supplier that we previously sourced. RentShare is a third

Note 7 - Accrued Liabilities

Note 7 - Accrued Liabilities	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	7. Accrued Liabilities Accrued liabilities consist of the following as of April 30, 2017 January 31 2017 ( April 30, January 31, 2017 2017 Accrued legal and professional fees $ 124 $ 94 Accrued payroll and related expenses 9 21 Accrued consulting 71 80 Other 183 189 $ 387 $ 384

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	3 Months Ended
	Apr. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	8. Commitments and Contingencies Executive Severance Commitments We have a severance compensation agreement with our Chief Executive Officer, Thomas Lanni. This agreement requires us to pay Mr. Lanni, in the event of a termination of employment following a change of control of the Company or certain other circumstances, the amount of his then current annual base salary and the amount of any bonus amount he would have achieved for the year in which the termination occurs plus the acceleration of unvested options. We have not Executive and Board of Directors Compensation On November 2, 2013, April 30, 2017, no not Legal Contingencies On February 13, 2015, On February 3, 2015, This lawsuit represents our most significant enforcement effort to date, and, together with the Targus and Best Buy lawsuits described elsewhere in this document, demonstrates our ongoing and accelerated efforts to methodically pursue those companies that we believe have infringed on the intellectual property estate that we have developed over the last 20 September 2015, inter partes 933 February 22, 2017, ruling in Apple’s favor. We believe the PTAB erred in its ruling, and we are appealing the ruling to the Court of Appeals for the Federal Circuit. We estimate that the appeals process will require approximately 12 may no no In addition to the pending matters described above, we are, from time to time, involved in various legal proceedings incidental to the conduct of our business. We are unable to predict the ultimate outcome of these matters.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying consolidated balance sheet as of January 31, 2017, three April 30, 2017 10 8 X. not not 10 January 31, 2017 “2016 10 May 1, 2017. 3 2017 10 three April 30, 2017 not January 31, 2018.
Reclassification, Policy [Policy Text Block]	Reclassification Certain prior year and prior period amounts have been reclassified for consistency with the current period presentation. These reclassifications had no
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The unaudited interim consolidated financial statements of the Company include the accounts of Comarco, Inc. and CWT, its wholly owned subsidiary. All material intercompany balances, transactions, and profits and losses have been eliminated.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the periods reported. Actual results could materially differ from those estimates. Certain accounting principles require subjective and complex judgments to be used in the preparation of financial statements. Accordingly, a different financial presentation could result depending on the judgments, estimates, or assumptions that are used. Such estimates and assumptions include, but are not
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents All highly liquid investments with original maturity dates of three
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Our financial instruments include cash and cash equivalents, accounts payable and accrued liabilities. The carrying amount of cash and cash equivalents, accounts payable, and accrued liabilities are considered to be representative of their respective fair values because of the short-term nature of those instruments.
Selling, General and Administrative Expenses, Policy [Policy Text Block]	Legal expense classification Our legal expenses are classified in either selling, general, and administrative expenses. All legal expenses incurred related to our intellectual property, including associated litigation expense and maintenance of our patent portfolio, public company legal expense, and all other litigation expense are included in selling, general, and administrative expenses in our consolidated statement of operations.
Income Tax, Policy [Policy Text Block]	Income tax expense Significant management judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and any required valuation allowance. We continue to maintain a full valuation allowance on the entire deferred tax asset balance. This valuation allowance was established based on management’s overall assessment of risks and uncertainties related to our future ability to realize, and hence, utilize certain deferred tax assets, primarily consisting of net operating loss carry forwards and temporary differences. Due to the current and prior years’ operating losses, the adjusted net deferred tax assets remained fully reserved as of April 30, 2017.
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) Per Common Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period excluding the dilutive effect of potential common stock, which for us consists solely of stock awards. Diluted earnings per share reflects the dilution that would result from the exercise of all dilutive stock awards outstanding during the period. The effect of such potential common stock is computed using the treasury stock method (see Note 5
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In February 2016, 2016 02, 842 2016 02” 2016 02 December 15, 2018, 2016 02 first 2020. not not In May 2014, 2014 09, 606 2014 09 five 2014 09 April 1, 2015, one December 15, 2018. 2014 09 first 2020. not not not We do not not
Subsequent Events, Policy [Policy Text Block]	Subsequent Events Management has evaluated events subsequent to April 30, 2017 may As of April 1, 2017, $4,500 $3,000 $1,500 $1,250 $0 $1,250 10Q $3.0

Note 4 - Stock-Based Compensa15

Note 4 - Stock-Based Compensation (Tables)	3 Months Ended
	Apr. 30, 2017
Notes Tables
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Three Months Ended April 30, 2017 2016 Stock-based compensation expense $ 7 $ 13 Impact on basic and diluted earnings per share $ (0.00 ) $ (0.00 )
Share-based Compensation, Stock Options, Activity [Table Text Block]	Outstanding Options Weighted-Ave. Number of Exercise Shares Price Balance, January 31, 2017 1,100,000 $ 0.37 Options granted - - Options canceled or expired - - Options exercise - - Balance, April 30, 2017 1,100,000 $ 0.37 Stock Options Exercisable at April 30, 2017 760,000 $ 0.44
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	Awards Outstanding Options Exercisable Weighted-Ave. Range of Number Remaining Weighted-Ave. Number Weighted-Ave. Exercise/Grant Prices Outstanding Contractual Life Exercise/Grant Price Exercisable Exercise Price $0.09 300,000 9.50 $ 0.09 - $ 0.09 $0.14 - $0.16 300,000 8.14 $ 0.15 300,000 $ 0.15 $0.40 385,000 5.26 $ 0.40 385,000 $ 0.40 $1.09 100,000 1.53 $ 1.09 60,000 $ 1.09 $4.53 15,000 0.84 $ 4.53 15,000 $ 4.53 1,100,000 760,000

Note 5 - Net (Loss) Income Pe16

Note 5 - Net (Loss) Income Per Share (Tables)	3 Months Ended
	Apr. 30, 2017
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended April 30, 2017 2016 Net (loss) income $ (222 ) $ 1,324 Basic net income (loss) per share: Weighted-average shares outstanding-Basic 14,615 14,644 Basic net (loss) income per share $ (0.02 ) $ 0.09 Diluted net (loss) income per share: Weighted average shares outstanding - basic 14,615 14,644 Effect of potentially dilutive securities - - Weighted average shares outstanding - diluted 14,615 14,644 Diluted net (loss) income per share $ (0.02 ) $ 0.09

Note 6 - Concentrations (Tables

Note 6 - Concentrations (Tables)	3 Months Ended
	Apr. 30, 2017
Notes Tables
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]	As of April 30, As of January 31, 2017 2017 Total gross accounts payable $ 9 100 % $ 6 100 % Vendor concentration: Fuan Gee Mechanical Industrial Co. 3 34 % 3 50 % RentShare 2 22 % 2 33 % CNA Insurance 2 22 % 1 17 % Computershare, Inc. 2 22 % - 0 % $ 9 100 % $ 6 100 %

Note 7 - Accrued Liabilities (T

Note 7 - Accrued Liabilities (Tables)	3 Months Ended
	Apr. 30, 2017
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	April 30, January 31, 2017 2017 Accrued legal and professional fees $ 124 $ 94 Accrued payroll and related expenses 9 21 Accrued consulting 71 80 Other 183 189 $ 387 $ 384

Note 2 - Current Developments19

Note 2 - Current Developments, Future Operations, Liquidity and Capital Resources (Details Textual)	Apr. 30, 2017USD ($)
Working Capital	$ 20,000

Note 3 - Summary of Significa20

Note 3 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	Apr. 01, 2017	Mar. 31, 2017
Deferred Compensation, Cash Net of Liabilities, Maximum	$ 3,000,000
Board of Directors Chairman [Member]
Monthly Cash Compensation	3,000	$ 4,500
Monthly Deferred Compensation	1,500
Director [Member]
Monthly Cash Compensation	0	$ 1,250
Monthly Deferred Compensation	$ 1,250

Note 4 - Stock-Based Compensa21

Note 4 - Stock-Based Compensation (Details Textual) - USD ($)	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 13,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0
Share Price	$ 0.06
Common Stock, Capital Shares Reserved for Future Issuance	323,535
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	0	0

Note 4 - Stock-Based Compensa22

Note 4 - Stock-Based Compensation - Share-based Compensation Expense (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Stock-based compensation expense	$ 7	$ 13
Impact on basic and diluted earnings per share (in dollars per share)	$ 0	$ 0

Note 4 - Stock-Based Compensa23

Note 4 - Stock-Based Compensation - Stock Options Activity (Details) - $ / shares	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Balance, stock options (in shares)	1,100,000
Balance, stock options, weighted-average exercise price (in dollars per share)	$ 0.37
Options granted (in shares)	0	0
Options granted, weighted-average exercise price (in dollars per share)
Options canceled or expired (in shares)
Options canceled or expired, weighted-average exercise price (in dollars per share)
Options exercise (in shares)
Options exercise, weighted-average exercise price (in dollars per share)
Balance, stock options, weighted-average exercise price (in dollars per share)	$ 0.37
Stock options exercisable (in shares)	760,000
Balance, stock options (in shares)	1,100,000
Stock options exercisable, weighted-average exercise price (in dollars per share)	$ 0.44

Note 4 - Stock-Based Compensa24

Note 4 - Stock-Based Compensation - Stock Awards Outstanding (Details)	3 Months Ended
	Apr. 30, 2017$ / sharesshares
Exercisable Number Exercisable (in shares) | shares	760,000
Number Outstanding (in shares) | shares	1,100,000
Range 1 [Member]
Weighted-Ave. Remaining Contractual Life (Year)	9 years 182 days
Weighted-Ave. Exercise/Grant Price (in dollars per share)	$ 0.09
Exercisable Number Exercisable (in shares) | shares
Exercisable Weighted-Ave. Exercise Price (in dollars per share)	$ 0.09
Lower Range of Exercise/Grant Prices (in dollars per share)	0.09
Upper Range of Exercise/Grant Prices (in dollars per share)
Number Outstanding (in shares) | shares	300,000
Range 2 [Member]
Weighted-Ave. Remaining Contractual Life (Year)	8 years 51 days
Weighted-Ave. Exercise/Grant Price (in dollars per share)	$ 0.15
Exercisable Number Exercisable (in shares) | shares	300,000
Exercisable Weighted-Ave. Exercise Price (in dollars per share)	$ 0.15
Lower Range of Exercise/Grant Prices (in dollars per share)	0.14
Upper Range of Exercise/Grant Prices (in dollars per share)	$ 0.16
Number Outstanding (in shares) | shares	300,000
Range 3 [Member]
Weighted-Ave. Remaining Contractual Life (Year)	5 years 94 days
Weighted-Ave. Exercise/Grant Price (in dollars per share)	$ 0.40
Exercisable Number Exercisable (in shares) | shares	385,000
Exercisable Weighted-Ave. Exercise Price (in dollars per share)	$ 0.40
Lower Range of Exercise/Grant Prices (in dollars per share)	0.40
Upper Range of Exercise/Grant Prices (in dollars per share)
Number Outstanding (in shares) | shares	385,000
Range 4 [Member]
Weighted-Ave. Remaining Contractual Life (Year)	1 year 193 days
Weighted-Ave. Exercise/Grant Price (in dollars per share)	$ 1.09
Exercisable Number Exercisable (in shares) | shares	60,000
Exercisable Weighted-Ave. Exercise Price (in dollars per share)	$ 1.09
Lower Range of Exercise/Grant Prices (in dollars per share)	1.09
Upper Range of Exercise/Grant Prices (in dollars per share)
Number Outstanding (in shares) | shares	100,000
Range 5 [Member]
Weighted-Ave. Remaining Contractual Life (Year)	306 days
Weighted-Ave. Exercise/Grant Price (in dollars per share)	$ 4.53
Exercisable Number Exercisable (in shares) | shares	15,000
Exercisable Weighted-Ave. Exercise Price (in dollars per share)	$ 4.53
Lower Range of Exercise/Grant Prices (in dollars per share)	4.53
Upper Range of Exercise/Grant Prices (in dollars per share)
Number Outstanding (in shares) | shares	15,000

Note 5 - Net (Loss) Income Pe25

Note 5 - Net (Loss) Income Per Share (Details Textual) - shares	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,190,000	3,073,736

Note 5 - Net (Loss) Income Pe26

Note 5 - Net (Loss) Income Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2017	Apr. 30, 2016
Net (loss) income	$ (222)	$ 1,324
Basic net income (loss) per share:
Basic net (loss) income per share (in dollars per share)	$ (0.02)	$ 0.09
Diluted net (loss) income per share:
Weighted-average shares outstanding-Basic (in shares)	14,615	14,644
Effect of potentially dilutive securities (in shares)
Weighted average shares outstanding - diluted (in shares)	14,615	14,644
Diluted net (loss) income per share (in dollars per share)	$ (0.02)	$ 0.09

Note 6 - Concentrations - Suppl

Note 6 - Concentrations - Supplier Concentration Risk Accounts Payable (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2017	Jan. 31, 2017
Percentage, accounts payable	100.00%	100.00%
Accounts payable	$ 9	$ 6
Supplier Concentration Risk [Member] | Accounts Payable [Member]
Accounts payable	$ 9	$ 6
Concentration percentage, accounts payable	100.00%	100.00%
Supplier Concentration Risk [Member] | Fuan Gee Mechanical Industrial Co. [Member] | Accounts Payable [Member]
Accounts payable	$ 3	$ 3
Concentration percentage, accounts payable	34.00%	50.00%
Supplier Concentration Risk [Member] | RentShare [Member] | Accounts Payable [Member]
Accounts payable	$ 2	$ 2
Concentration percentage, accounts payable	22.00%	33.00%
Supplier Concentration Risk [Member] | CNA Insurance [Member] | Accounts Payable [Member]
Accounts payable	$ 2	$ 1
Concentration percentage, accounts payable	22.00%	17.00%
Supplier Concentration Risk [Member] | Computershare, Inc. [Member] | Accounts Payable [Member]
Accounts payable	$ 2
Concentration percentage, accounts payable	22.00%	0.00%

Note 7 - Accrued Liabilities -

Note 7 - Accrued Liabilities - Accrued Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2017	Jan. 31, 2017
Accrued legal and professional fees	$ 124	$ 94
Accrued payroll and related expenses	9	21
Accrued consulting	71	80
Other	183	189
	$ 387	$ 384

Note 8 - Commitments and Cont29

Note 8 - Commitments and Contingencies (Details Textual) $ in Thousands	Apr. 30, 2017USD ($)
Deferred Compensation Liability, Current and Noncurrent	$ 0